Efficacy and safety of rituximab in relapsing-remitting multiple sclerosis: A systematic review and meta-analysis

This study aimed to quantitatively review and summarize the effectiveness and safety of rituximab (RTX) treatment for patients with relapsing-remitting multiple sclerosis (RRMS).

Source: Journal of Neuroimmunology - July 8, 2020 Category: Allergy & Immunology Authors: Xin Tian, Chaoyang Chen, Lingyun Ma, Ran Wei, Min Li, Xiaoqing Wang, Ye Wu, Ying Zhou, Yimin Cui Tags: Review Article Source Type: research